Supergut mimics Ozempic, minus the bad stuff Founded in 2019 as Muniq, a gut supplement brand, the company rebranded to Supergut in 2022 to widen its focus to gut-healthy superfoods and appetite control, just as the uptake of GLP-1 agonist drugs like Wegovy and Ozempic began shaking up the pharma and food industries
GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective treatment options for obesity
Other silybin derivatives are in development, such as the silybinphosphatidylcholine complex, which has shown some efficacy with treatment of non-fatty liver disease (Ferenci, 2016)
If any of these signs appear, it is safer to discard the peptide and obtain a new supply
Getting labs through your primary care physician before starting is a good practice
Intracranial lesions must be inactive and antitumor therepy complete prior to the institution of therapy